During the past decade, Perseverance Research Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Perseverance Research Center" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Perseverance Research Center, LLC" with 3 trials sponsored, "RAPT Therapeutics, Inc." with 2 trials sponsored and "BioVie Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Perseverance Research Center" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "Athena Medical Group" with 1 trials as a collaborator, "Cerulean Advanced Fitness and Wellness" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Perseverance Research Center" are "Agitation in Patients With Dementia of the Alzheimer's Type" (3 trials), "Alzheimer Disease" (3 trials), "Migraine" (3 trials), "Atopic Dermatitis" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Perseverance Research Center" in a lesser frequency.

Most popular intervention types in "Perseverance Research Center" are "Drug" (17 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "AVP-786" (3 trials), "Lasmiditan" (3 trials), "RPT193" (2 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Perseverance Research Center" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Perseverance Research Center". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Perseverance Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Perseverance Research Center, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".